Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Point of Care (POC) Analyzers Pipeline Market Report Overview

POC analyzers are small handheld or bench-top analyzers often used in small laboratories and physician labs with less workload and daily sample inflow. They often use disposable test cartridges and can provide faster results. The Point of Care (POC) analyzers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        POC Hand Held Hematology Analyzers

·        POC Immunochemistry Analyzers

·        POC PCR Systems

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        India

Key Regulatory Paths ·        510(k)

·        CE-IVD

·        MDL

·        NMPA

·        ICAC

Leading Companies ·        Access Bio Inc

·        Acousort AB

·        Acrongenomics Inc (Inactive)

·        AgPlus Diagnostics LTD

·        Akonni Biosystems Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Point of Care (POC) Analyzers Pipeline Market by Segments

The key segments in the Point of Care (POC) analyzers pipeline market are POC Hand Held Hematology Analyzers, POC Immunochemistry Analyzers, and POC PCR Systems. As of December 2023, POC Hand Held Hematology Analyzers accounted for the highest number of pipeline products. POC Hematology Analyzers are small hand-held analyzers used to perform tests related to blood and blood components. These analyzers are also used to identify and determine the morphology of blood and blood-forming cells.

Point of Care (POC) Analyzers Pipeline Market Analysis by Segments, 2023 (%)

Point of Care (POC) Analyzers Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Point of Care (POC) Analyzers Pipeline Market

Download a Free Report Sample

Point of Care (POC) Analyzers Pipeline Market Segmentation by Territories

A few of the key territories for Point of Care (POC) analyzers pipeline products are the US, Europe, Canada, China, and India. As of December 2023, the US accounted for the highest number of pipeline products.

Point of Care (POC) Analyzers Pipeline Market Analysis by Territories, 2023 (%)

Point of Care (POC) Analyzers Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Point of Care (POC) Analyzers Pipeline Market

Download a Free Report Sample

Point of Care (POC) Analyzers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Point of Care (POC) analyzers pipeline market are 510(k), CE-IVD, MDL, NMPA, and ICAC. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Point of Care (POC) Analyzers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Point of Care (POC) Analyzers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Point of Care (POC) Analyzers Pipeline Market

Download a Free Report Sample

Point of Care (POC) Analyzers Pipeline Market – Competitive Landscape

A few of the key companies associated with the Point of Care (POC) analyzers pipeline market are Access Bio Inc., Acousort AB, Acrongenomics Inc. (Inactive), AgPlus Diagnostics LTD, and Akonni Biosystems Inc., among others.

Access Bio Inc: Access Bio is headquartered in Somerset, New Jersey, the US. It operates through its research and development and production facility located in Seoul, Korea. Besides the US and Korea, the company has a presence in Ethiopia as well. Access Bio is a medical device company that researches, develops, manufactures, and markets in-vitro diagnostics tests, biosensors, and molecular diagnostic products. The company serves non-profit organizations and private companies.

Akonni Biosystems Inc: Akonni Biosystems is headquartered in Frederick, Maryland, the US. It is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company products find applications in therapeutical areas of infectious disease, oncology, and pharmacogenomics, among others. Akonni Biosystems partners with laboratories, biodefense companies, and universities.

Point of Care (POC) Analyzers Pipeline Market Analysis by Companies, 2023

Point of Care (POC) Analyzers Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Point of Care (POC) Analyzers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Point of Care (POC) Analyzers Pipeline Market Segments Outlook

  • POC Hand Held Hematology Analyzers
  • POC Immunochemistry Analyzers
  • POC PCR Systems

Point of Care (POC) Analyzers Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • India

Point of Care (POC) Analyzers Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE-IVD
  • MDL
  • NMPA
  • ICAC

Scope

This report provides:

  • Extensive coverage of the Point of Care (POC) Analyzers under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Point of Care (POC) analyzers and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Point of Care (POC) analyzers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Access Bio Inc
Acousort AB
Acrongenomics Inc (Inactive)
AgPlus Diagnostics LTD
Akonni Biosystems Inc
Alere Inc
All Medicus Co Ltd
Analytical Diagnostic Solutions Inc
ApoCell Inc
Aptatek BioSciences Inc
AquaBioChip, LLC
Atonomics A/S (Inactive)
Aviv Biomedical, Inc.
Besst Test
Binghamton University
Bio-AMD Inc
BioMedomics Inc
Biopico Systems Inc
Biosensia Ltd
Boston University
BreviTest Technologies LLC
Brigham and Women's Hospital
Canon USA Inc
Center for Innovation in Point-of-Care Technologies for HIV/AIDS
ChipCare Corp
Chrogene Aarogyam Biotech Pvt Ltd
Chronus Health Inc
City, University of London
Co-Diagnostics Inc
Cornell University
Curetis GmbH
Duke University
Edan Instruments Inc
EKF Diagnostics Holdings Plc
Electrocyt, Inc.
Emergent Detection Inc (Inactive)
Endeavor Sciences Inc
Entegrion Inc
ExcitePCR Corp
Fable Biyoteknoloji San ve Tic AS
Fawkes Biotechnology LLC
First Light Diagnostics Inc
Florida International University
Future Diagnostics Solutions BV
General Fluidics Corp
Giner Inc
GlucoSentient Inc
Glyconics Ltd
Haemokinesis Pty Ltd
HemoPalm Corp
IdbyDNA Inc
Indian Institute of Science
Intelligent Optical Systems, Inc.
Invivomon Inc (Inactive)
I-Sens Inc
LabNow Inc (Inactive)
LightDeck Diagnostics Inc
Louisiana State University
Lucendi Inc
Masaryk University
Maxygen-mobile DNA tests
McKesson Corp
Memorial Sloan Kettering Cancer Center
MobioSense Inc
MyMD Pharmaceuticals Inc
Nalia Systems Ltd
Nanomix Inc
NeuroCatch Inc
Newcastle University
Nikkiso Co Ltd
Nova Biomedical Corp
Novel Microdevices LLC
Ohmx Corp
OncoGenesis
Ontera Inc (Inactive)
Oregon State University
Pacific Nanoscience, Inc.
POC Medical Systems Inc
Prominex Inc
Qvella Corp
Radisens Diagnostics Ltd
Rapid Diagnostic Pvt Ltd
RMIT University
Samvardhana Motherson Health Solution Ltd
Scryb Inc
SeLux Diagnostics Inc
SenGenix Inc
SepTec
Smiths Detection Inc
StemTek Therapeutics SL
Sugentech Inc
Thermal Gradient Inc
ThreeFold Sensors (Inactive)
Trinity Biotech Plc
University of Calgary
University of California Berkeley
University of Glasgow
University of Illinois at Urbana-Champaign
University of Pittsburgh
Ural Federal University
ViroGates AS
Wellstat Diagnostics LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 15

2 Introduction 16

2.1 Point of Care (POC) Analyzers Overview 16

3 Products under Development 17

3.1 Point of Care (POC) Analyzers – Pipeline Products by Stage of Development 17

3.2 Point of Care (POC) Analyzers – Pipeline Products by Segment 18

3.3 Point of Care (POC) Analyzers – Pipeline Products by Territory 19

3.4 Point of Care (POC) Analyzers – Pipeline Products by Regulatory Path 20

3.5 Point of Care (POC) Analyzers – Pipeline Products by Estimated Approval Date 21

3.6 Point of Care (POC) Analyzers – Ongoing Clinical Trials 22

4 Point of Care (POC) Analyzers – Pipeline Products under Development by Companies 23

4.1 Point of Care (POC) Analyzers Companies – Pipeline Products by Stage of Development 23

4.2 Point of Care (POC) Analyzers – Pipeline Products by Stage of Development 27

5 Point of Care (POC) Analyzers Companies and Product Overview 30

5.1 Access Bio Inc Company Overview 30

5.1.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.2 Acousort AB Company Overview 31

5.2.1 Acousort AB Pipeline Products & Ongoing Clinical Trials Overview 31

5.3 Acrongenomics Inc (Inactive) Company Overview 32

5.3.1 Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

5.4 AgPlus Diagnostics LTD Company Overview 34

5.4.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 34

5.5 Akonni Biosystems Inc Company Overview 35

5.5.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Alere Inc Company Overview 36

5.6.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.7 All Medicus Co Ltd Company Overview 37

5.7.1 All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.8 Analytical Diagnostic Solutions Inc Company Overview 38

5.8.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 ApoCell Inc Company Overview 40

5.9.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 Aptatek BioSciences Inc Company Overview 41

5.10.1 Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 AquaBioChip, LLC Company Overview 44

5.11.1 AquaBioChip, LLC Pipeline Products & Ongoing Clinical Trials Overview 44

5.12 Atonomics A/S (Inactive) Company Overview 45

5.12.1 Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

5.13 Aviv Biomedical, Inc. Company Overview 46

5.13.1 Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46

5.14 Besst Test Company Overview 47

5.14.1 Besst Test Pipeline Products & Ongoing Clinical Trials Overview 47

5.15 Binghamton University Company Overview 48

5.15.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Bio-AMD Inc Company Overview 50

5.16.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.17 BioMedomics Inc Company Overview 52

5.17.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.18 Biopico Systems Inc Company Overview 53

5.18.1 Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.19 Biosensia Ltd Company Overview 54

5.19.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.20 Boston University Company Overview 55

5.20.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 BreviTest Technologies LLC Company Overview 56

5.21.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.22 Brigham and Women’s Hospital Company Overview 58

5.22.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 58

5.23 Canon USA Inc Company Overview 59

5.23.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.24 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview 60

5.24.1 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Pipeline Products & Ongoing Clinical Trials Overview 60

5.25 ChipCare Corp Company Overview 62

5.25.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 62

5.26 Chrogene Aarogyam Biotech Pvt Ltd Company Overview 63

5.26.1 Chrogene Aarogyam Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.27 Chronus Health Inc Company Overview 64

5.27.1 Chronus Health Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.28 City, University of London Company Overview 65

5.28.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 65

5.29 Co-Diagnostics Inc Company Overview 66

5.29.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.30 Cornell University Company Overview 68

5.30.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 68

5.31 Curetis GmbH Company Overview 69

5.31.1 Curetis GmbH Pipeline Products & Ongoing Clinical Trials Overview 69

5.32 Duke University Company Overview 70

5.32.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 70

5.33 Edan Instruments Inc Company Overview 71

5.33.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.34 EKF Diagnostics Holdings Plc Company Overview 72

5.34.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 72

5.35 Electrocyt, Inc. Company Overview 77

5.35.1 Electrocyt, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

5.36 Emergent Detection Inc (Inactive) Company Overview 78

5.36.1 Emergent Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

5.37 Endeavor Sciences Inc Company Overview 79

5.37.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.38 Entegrion Inc Company Overview 80

5.38.1 Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.39 ExcitePCR Corp Company Overview 81

5.39.1 ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 81

5.40 Fable Biyoteknoloji San ve Tic AS Company Overview 83

5.40.1 Fable Biyoteknoloji San ve Tic AS Pipeline Products & Ongoing Clinical Trials Overview 83

5.41 Fawkes Biotechnology LLC Company Overview 84

5.41.1 Fawkes Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 84

5.42 First Light Diagnostics Inc Company Overview 85

5.42.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.43 Florida International University Company Overview 86

5.43.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 86

5.44 Future Diagnostics Solutions BV Company Overview 87

5.44.1 Future Diagnostics Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 87

5.45 General Fluidics Corp Company Overview 88

5.45.1 General Fluidics Corp Pipeline Products & Ongoing Clinical Trials Overview 88

5.46 Giner Inc Company Overview 89

5.46.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.47 GlucoSentient Inc Company Overview 90

5.47.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.48 Glyconics Ltd Company Overview 92

5.48.1 Glyconics Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.49 Haemokinesis Pty Ltd Company Overview 93

5.49.1 Haemokinesis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.50 HemoPalm Corp Company Overview 94

5.50.1 HemoPalm Corp Pipeline Products & Ongoing Clinical Trials Overview 94

5.51 IdbyDNA Inc Company Overview 96

5.51.1 IdbyDNA Inc Pipeline Products & Ongoing Clinical Trials Overview 96

5.52 Indian Institute of Science Company Overview 97

5.52.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 97

5.53 Intelligent Optical Systems, Inc. Company Overview 99

5.53.1 Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99

5.54 Invivomon Inc (Inactive) Company Overview 100

5.54.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 100

5.55 I-Sens Inc Company Overview 101

5.55.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.56 LabNow Inc (Inactive) Company Overview 102

5.56.1 LabNow Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 102

5.57 LightDeck Diagnostics Inc Company Overview 103

5.57.1 LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.58 Louisiana State University Company Overview 105

5.58.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 105

5.59 Lucendi Inc Company Overview 106

5.59.1 Lucendi Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.60 Masaryk University Company Overview 107

5.60.1 Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 107

5.61 Maxygen-mobile DNA tests Company Overview 108

5.61.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 108

5.62 McKesson Corp Company Overview 109

5.62.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 109

5.63 Memorial Sloan Kettering Cancer Center Company Overview 110

5.63.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 110

5.64 MobioSense Inc Company Overview 111

5.64.1 MobioSense Inc Pipeline Products & Ongoing Clinical Trials Overview 111

5.65 MyMD Pharmaceuticals Inc Company Overview 112

5.65.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.66 Nalia Systems Ltd Company Overview 113

5.66.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

5.67 Nanomix Inc Company Overview 114

5.67.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.68 NeuroCatch Inc Company Overview 115

5.68.1 NeuroCatch Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.69 Newcastle University Company Overview 118

5.69.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 118

5.70 Nikkiso Co Ltd Company Overview 121

5.70.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

5.71 Nova Biomedical Corp Company Overview 122

5.71.1 Nova Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 122

5.72 Novel Microdevices LLC Company Overview 124

5.72.1 Novel Microdevices LLC Pipeline Products & Ongoing Clinical Trials Overview 124

5.73 Ohmx Corp Company Overview 125

5.73.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 125

5.74 OncoGenesis Company Overview 126

5.74.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 126

5.75 Ontera Inc (Inactive) Company Overview 127

5.75.1 Ontera Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 127

5.76 Oregon State University Company Overview 128

5.76.1 Oregon State University Pipeline Products & Ongoing Clinical Trials Overview 128

5.77 Pacific Nanoscience, Inc. Company Overview 129

5.77.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129

5.78 POC Medical Systems Inc Company Overview 130

5.78.1 POC Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 130

5.79 Prominex Inc Company Overview 131

5.79.1 Prominex Inc Pipeline Products & Ongoing Clinical Trials Overview 131

5.80 Qvella Corp Company Overview 132

5.80.1 Qvella Corp Pipeline Products & Ongoing Clinical Trials Overview 132

5.81 Radisens Diagnostics Ltd Company Overview 133

5.81.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 133

5.82 Rapid Diagnostic Pvt Ltd Company Overview 134

5.82.1 Rapid Diagnostic Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

5.83 RMIT University Company Overview 135

5.83.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 135

5.84 Samvardhana Motherson Health Solution Ltd Company Overview 136

5.84.1 Samvardhana Motherson Health Solution Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.85 Scryb Inc Company Overview 137

5.85.1 Scryb Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.86 SeLux Diagnostics Inc Company Overview 138

5.86.1 SeLux Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.87 SenGenix Inc Company Overview 139

5.87.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.88 SepTec Company Overview 140

5.88.1 SepTec Pipeline Products & Ongoing Clinical Trials Overview 140

5.89 Smiths Detection Inc Company Overview 141

5.89.1 Smiths Detection Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.90 StemTek Therapeutics SL Company Overview 142

5.90.1 StemTek Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 142

5.91 Sugentech Inc Company Overview 143

5.91.1 Sugentech Inc Pipeline Products & Ongoing Clinical Trials Overview 143

5.92 Thermal Gradient Inc Company Overview 144

5.92.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.93 ThreeFold Sensors (Inactive) Company Overview 146

5.93.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 146

5.94 Trinity Biotech Plc Company Overview 147

5.94.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 147

5.95 University of Calgary Company Overview 149

5.95.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 149

5.96 University of California Berkeley Company Overview 150

5.96.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 150

5.97 University of Glasgow Company Overview 152

5.97.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 152

5.98 University of Illinois at Urbana-Champaign Company Overview 155

5.98.1 University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview 155

5.99 University of Pittsburgh Company Overview 157

5.99.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 157

5.100 Ural Federal University Company Overview 158

5.100.1 Ural Federal University Pipeline Products & Ongoing Clinical Trials Overview 158

5.101 ViroGates AS Company Overview 159

5.101.1 ViroGates AS Pipeline Products & Ongoing Clinical Trials Overview 159

5.102 Wellstat Diagnostics LLC Company Overview 160

5.102.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 160

6 Point of Care (POC) Analyzers- Recent Developments 161

6.1 Nov 29, 2023: BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer 161

6.2 Nov 01, 2023: McKesson Corp. Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance 161

6.3 Oct 18, 2023: Procisedx Expands Intellectual Property Portfolio With Purchase of Two US Therapeutic Drug Monitoring Patents 162

6.4 Oct 16, 2023: Alere Receives Additional 510(K) Clearance For Alere Afinion AS100 Analyzer 162

6.5 Oct 13, 2023: Alere Receives Additional 510(K) Clearance for Cholestech LDX Analyzer 163

6.6 Oct 12, 2023: Alere Receives 510(K) Clearance For Afinion 2 Analyzer 163

6.7 Aug 29, 2023: Co-Diagnostics Appoints Chief Regulatory Affairs Officer 163

6.8 Aug 28, 2023: AI Analysis of a Handheld Device Holds Potential to Speed Up Detection of Heart Failure 164

6.9 Aug 23, 2023: Medical Electronic Systems Receives 510(k) Clearance for SQA-iO Sperm Quality Analyzer 165

6.10 Aug 22, 2023: HealthtrackRx Expands National Footprint With Los Angeles Area PCR Laboratory 165

6.11 Aug 08, 2023: HealthTab Signs Reseller Agreement With Abbott to Support UK Expansion 165

6.12 Aug 01, 2023: AXIM Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test 166

6.13 Jul 31, 2023: LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests 168

6.14 Jul 27, 2023: Lumos Secures Feasibility Project with Burnet Diagnostics Initiative 168

6.15 Jul 14, 2023: Introducing the Anbio AF-100S: A Small, Yet Powerful Handheld Analyzer for Rapid, Point-of-Care Testing 169

6.16 Jun 27, 2023: bioMErieux’s Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations 169

6.17 Jun 21, 2023: EDAN Showcases at FIME 2023 for Tapping New Potential in the Americas Market 170

6.18 May 26, 2023: The goal is to create a “biological computer”, empower primary medical inspections and upgrades, and realize intelligent health data management 170

6.19 May 08, 2023: McKesson reports fiscal fourth-quarter and full-year results and raises long-term segment growth targets 173

6.20 May 05, 2023: Co-Diagnostics announces first quarter 2023 earnings release date and webcast 176

6.21 Mar 09, 2023: Co-diagnostics Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Webcast 177

6.22 Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022 177

6.23 Feb 22, 2023: Shenzhen Superbio Technology receives additional CLIA clearance for Superbio Immunofluorescence Analyzer EASY-11 178

6.24 Feb 02, 2023: Instrumentation Laboratory receives additional 510(k) clearance for GEM Premier ChemSTAT 179

6.25 Feb 02, 2023: SeLux Diagnostics receives CLIA approval for Selux AST System (Model AST Gen

1.0) 179

6.26 Jan 24, 2023: SeLux Diagnostics obtains 510(k) clearance for Selux AST System (Model AST Gen

1.0) 179

6.27 Jan 20, 2023: Selux Diagnostics secures FDA 510(k) clearance for AST testing NGP System 179

6.28 Jan 18, 2023: Cipla launches Cippoint – a point-of-care device for non communicable diseases, infectious diseases, and other health conditions 180

6.29 Jan 04, 2023: Shenzhen Superbio Technology receives CLIA clearance for Superbio Immunofluorescence Analyzer EASY-11 180

6.30 Dec 27, 2022: Shenzhen Superbio Technology receives 510(k) clearance for Superbio Immunofluorescence Analyzer EASY-11 180

7 Appendix 182

7.1 Methodology 182

7.2 About GlobalData 185

7.3 Contact Us 185

7.4 Disclaimer 185

Table

Point of Care (POC) Analyzers – Pipeline Products by Stage of Development 17

Point of Care (POC) Analyzers – Pipeline Products by Segment 18

Point of Care (POC) Analyzers – Pipeline Products by Territory 19

Point of Care (POC) Analyzers – Pipeline Products by Regulatory Path 20

Point of Care (POC) Analyzers – Pipeline Products by Estimated Approval Date 21

Point of Care (POC) Analyzers – Ongoing Clinical Trials 22

Point of Care (POC) Analyzers Companies – Pipeline Products by Stage of Development 23

Point of Care (POC) Analyzers – Pipeline Products by Stage of Development 27

Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 30

All-in-One Sensor – Product Status 30

All-in-One Sensor – Product Description 30

Acousort AB Pipeline Products & Ongoing Clinical Trials Overview 31

POC Diagnostic System – Blood Analysis – Product Status 31

POC Diagnostic System – Blood Analysis – Product Description 31

Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

BioLED Device – Cardiovascular Diseases – Product Status 32

BioLED Device – Cardiovascular Diseases – Product Description 32

BioLED Device – Diabetes Management – Product Status 33

BioLED Device – Diabetes Management – Product Description 33

AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 34

AgPlus Diagnostic System – Product Status 34

AgPlus Diagnostic System – Product Description 34

Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 35

TruDx 2000 Platform – Product Status 35

TruDx 2000 Platform – Product Description 35

Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Clondiag HIV Molecular Device – Product Status 36

Clondiag HIV Molecular Device – Product Description 36

All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Biosensor System – AST/ALT – Product Status 37

Biosensor System – AST/ALT – Product Description 37

Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 38

BiliNow – Product Status 38

BiliNow – Product Description 38

PKU Now – Product Status 39

PKU Now – Product Description 39

ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 40

ApoStream System – Product Status 40

ApoStream System – Product Description 40

Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Point Of Care Diagnostic Device – Phenylketonuria – Product Status 41

Point Of Care Diagnostic Device – Phenylketonuria – Product Description 41

Aptatek BioSciences Inc – Ongoing Clinical Trials Overview 42

Point Of Care Diagnostic Device – Phenylketonuria – PheCheck Feasibility Study 43

AquaBioChip, LLC Pipeline Products & Ongoing Clinical Trials Overview 44

Gene-Z Device – Product Status 44

Gene-Z Device – Product Description 44

Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

Atolyzer PoC – Product Status 45

Atolyzer PoC – Product Description 45

Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46

AVIV-BHS (Bilirubin Hematofluorometer System) – Product Status 46

AVIV-BHS (Bilirubin Hematofluorometer System) – Product Description 46

Besst Test Pipeline Products & Ongoing Clinical Trials Overview 47

Human Blood Coagulation Monitoring Device – Product Status 47

Human Blood Coagulation Monitoring Device – Product Description 47

Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 48

U-PAC – Product Status 48

U-PAC – Product Description 49

Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Magnetic Immunoassay Detection System – Product Status 50

Magnetic Immunoassay Detection System – Product Description 51

BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

TR-LFIA Diagnostic Analyzer – Product Status 52

TR-LFIA Diagnostic Analyzer – Product Description 52

Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 53

MONITOR (Multiplexed Onchip Nanomagnetic Immunoassay for Toxin Reporting) System – Product Status 53

MONITOR (Multiplexed Onchip Nanomagnetic Immunoassay for Toxin Reporting) System – Product Description 53

Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

RapiPlex System – Product Status 54

RapiPlex System – Product Description 54

Boston University Pipeline Products & Ongoing Clinical Trials Overview 55

Point-Of-Care Device – Allergen-Specific IgE – Product Status 55

Point-Of-Care Device – Allergen-Specific IgE – Product Description 55

BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56

BreviTest Portable Analyzer – Product Status 56

BreviTest Portable Analyzer – Product Description 56

BreviTest Portable Analyzer – Vitamin D – Product Status 57

BreviTest Portable Analyzer – Vitamin D – Product Description 57

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 58

Semen Analyzer – Product Status 58

Semen Analyzer – Product Description 58

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Automated Diagnostic System – Infectious Disease – Product Status 59

Automated Diagnostic System – Infectious Disease – Product Description 59

Center for Innovation in Point-of-Care Technologies for HIV/AIDS Pipeline Products & Ongoing Clinical Trials Overview 60

Point Of Care Device – Cancer – Product Status 60

Point Of Care Device – Cancer – Product Description 60

Point Of Care Device – Diabetes – Product Status 61

Point Of Care Device – Diabetes – Product Description 61

Point Of Care Device – Heart Disease – Product Status 61

Point Of Care Device – Heart Disease – Product Description 61

ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 62

Polyvalent Analyzer (PAx) – Product Status 62

Polyvalent Analyzer (PAx) – Product Description 62

Chrogene Aarogyam Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Point-Of-Care Device – Sickle Cell Disease – Product Status 63

Point-Of-Care Device – Sickle Cell Disease – Product Description 63

Chronus Health Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Portable Diagnostic Device – CBC And CMP – Product Status 64

Portable Diagnostic Device – CBC And CMP – Product Description 64

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 65

POC Device – Mood Disorders – Product Status 65

POC Device – Mood Disorders – Product Description 65

Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Co-Dx PCR Pro Testing Device – Product Status 66

Co-Dx PCR Pro Testing Device – Product Description 66

LightPCR – Product Status 67

LightPCR – Product Description 67

Cornell University Pipeline Products & Ongoing Clinical Trials Overview 68

AnemiaPhone – Product Status 68

AnemiaPhone – Product Description 68

Curetis GmbH Pipeline Products & Ongoing Clinical Trials Overview 69

Unyvero Analyzer A30 RQ – Product Status 69

Unyvero Analyzer A30 RQ – Product Description 69

Duke University Pipeline Products & Ongoing Clinical Trials Overview 70

Point-Of-Care Diagnostic Tool – Product Status 70

Point-Of-Care Diagnostic Tool – Product Description 70

Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 71

i20 Blood Gas And Chemistry Analysis System – Product Status 71

i20 Blood Gas And Chemistry Analysis System – Product Description 71

EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 72

B-HB POC Analyser – Product Status 72

B-HB POC Analyser – Product Description 73

BIOSEN HbA1c Instrument – Product Status 73

BIOSEN HbA1c Instrument – Product Description 73

DiaSpect Tm – Product Status 74

DiaSpect Tm – Product Description 74

Lactate Scout 4 – Clinic Use – Product Status 74

Lactate Scout 4 – Clinic Use – Product Description 75

SensPoint – Product Status 75

SensPoint – Product Description 75

Serum/Plasma Analyser – Product Status 76

Serum/Plasma Analyser – Product Description 76

Electrocyt, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

LifeCounts – Product Status 77

LifeCounts – Product Description 77

Emergent Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

BodyKey – Product Status 78

BodyKey – Product Description 78

Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 79

SPARKS Mobile – Product Status 79

SPARKS Mobile – Product Description 79

Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Viscoelastic Coagulation Monitor – Product Status 80

Viscoelastic Coagulation Monitor – Product Description 80

ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 81

FireflyDX-Handheld – Product Status 81

FireflyDX-Handheld – Product Description 82

Fable Biyoteknoloji San ve Tic AS Pipeline Products & Ongoing Clinical Trials Overview 83

AP-23 Point of Care System – Product Status 83

AP-23 Point of Care System – Product Description 83

Fawkes Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 84

Lateral Flow Device – Product Status 84

Lateral Flow Device – Product Description 84

First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 85

MultiPath Analyzer – Product Status 85

MultiPath Analyzer – Product Description 85

Florida International University Pipeline Products & Ongoing Clinical Trials Overview 86

Cortisol Detector – Product Status 86

Cortisol Detector – Product Description 86

Future Diagnostics Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 87

Point-of-Care Device – Cancer – Product Status 87

Point-of-Care Device – Cancer – Product Description 87

General Fluidics Corp Pipeline Products & Ongoing Clinical Trials Overview 88

Axess System – Product Status 88

Axess System – Product Description 88

Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Home Monitoring System – Blood Lithium – Product Status 89

Home Monitoring System – Blood Lithium – Product Description 89

GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Home Use Device – Phenylketonuria – Product Status 90

Home Use Device – Phenylketonuria – Product Description 90

Point Of Care Device – Bronchiolitis Obliterans Syndrome – Product Status 91

Point Of Care Device – Bronchiolitis Obliterans Syndrome – Product Description 91

Glyconics Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

Glyconics-SX System – Product Status 92

Glyconics-SX System – Product Description 92

Haemokinesis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

Rapid Blood-Type Test Analyser – Product Status 93

Rapid Blood-Type Test Analyser – Product Description 93

HemoPalm Corp Pipeline Products & Ongoing Clinical Trials Overview 94

HemoPalm – Product Status 94

HemoPalm – Product Description 94

HemoPalm – Version 3 – Product Status 95

HemoPalm – Version 3 – Product Description 95

IdbyDNA Inc Pipeline Products & Ongoing Clinical Trials Overview 96

Multiplexed Diagnostic Device – Product Status 96

Multiplexed Diagnostic Device – Product Description 96

Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 97

Point-Of-Care Biosensor – Hemoglobin – Product Status 97

Point-Of-Care Biosensor – Hemoglobin – Product Description 97

Point-Of-Care Electrochemical Biosensor – Product Status 98

Point-Of-Care Electrochemical Biosensor – Product Description 98

Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99

Point-Of-Care Analyzer – Renal Function Test – Product Status 99

Point-Of-Care Analyzer – Renal Function Test – Product Description 99

Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 100

Miniature Analyzer – Product Status 100

Miniature Analyzer – Product Description 100

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 101

POCT Immunoassay Analyzer – Cardiac Marker – Product Status 101

POCT Immunoassay Analyzer – Cardiac Marker – Product Description 101

LabNow Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 102

CD4Now Analyzer – Product Status 102

CD4Now Analyzer – Product Description 102

LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 103

MBio Array System – Product Status 103

MBio Array System – Product Description 104

Point of Care Device – HIV – Product Status 104

Point of Care Device – HIV – Product Description 104

Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 105

FluoroZen – Product Status 105

FluoroZen – Product Description 105

Lucendi Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Semen Performance Analyzer – Product Status 106

Semen Performance Analyzer – Product Description 106

Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 107

Diagnostic Device – Methanol Poisoning – Product Status 107

Diagnostic Device – Methanol Poisoning – Product Description 107

Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 108

Maxygen POC Device – Product Status 108

Maxygen POC Device – Product Description 108

McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 109

Proventys PDx System – Product Status 109

Proventys PDx System – Product Description 109

Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 110

POC Biosensor Device – Product Status 110

POC Biosensor Device – Product Description 110

MobioSense Inc Pipeline Products & Ongoing Clinical Trials Overview 111

Point-Of-Care Device – Heart Failure – Product Status 111

Point-Of-Care Device – Heart Failure – Product Description 111

MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 112

minDNAnalyzer – Product Status 112

minDNAnalyzer – Product Description 112

Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

NALIA Single-Patient Point-Of-Care Device – Product Status 113

NALIA Single-Patient Point-Of-Care Device – Product Description 113

Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 114

Nanomix eLab System – Product Status 114

Nanomix eLab System – Product Description 114

NeuroCatch Inc Pipeline Products & Ongoing Clinical Trials Overview 115

NeuroCatch Device – Product Status 115

NeuroCatch Device – Product Description 115

NeuroCatch Inc – Ongoing Clinical Trials Overview 116

NeuroCatch Device – Neurophysiological Measurements in the Pediatric Concussion Population: An Initial Assessment Using the NeuroCatch Platform 117

Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 118

SmartHEALTH POC System – Breast Cancer – Product Status 118

SmartHEALTH POC System – Breast Cancer – Product Description 118

SmartHEALTH POC System – Cervical Cancer – Product Status 119

SmartHEALTH POC System – Cervical Cancer – Product Description 119

SmartHEALTH POC System – Colorectal Cancer – Product Status 119

SmartHEALTH POC System – Colorectal Cancer – Product Description 120

Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

Micro Fluidic Device – Product Status 121

Micro Fluidic Device – Product Description 121

Nova Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 122

Allegro Analyzer – Product Status 122

Allegro Analyzer – Product Description 122

StatStrip Hemoglobin and Hematocrit Meter System – Product Status 123

StatStrip Hemoglobin and Hematocrit Meter System – Product Description 123

Novel Microdevices LLC Pipeline Products & Ongoing Clinical Trials Overview 124

Novel Dx System – Product Status 124

Novel Dx System – Product Description 124

Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 125

Handheld Clinical Analyzer – Product Status 125

Handheld Clinical Analyzer – Product Description 125

OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 126

Genesis Point-Of-Care Diagnostic System – Product Status 126

Genesis Point-Of-Care Diagnostic System – Product Description 126

Ontera Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 127

MoM – Product Status 127

MoM – Product Description 127

Oregon State University Pipeline Products & Ongoing Clinical Trials Overview 128

Paper-Based Phenylalanine Test – Product Status 128

Paper-Based Phenylalanine Test – Product Description 128

Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129

Nanomonitor – Product Status 129

Nanomonitor – Product Description 129

POC Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 130

Pandora CDx Point-of-Care System – Product Status 130

Pandora CDx Point-of-Care System – Product Description 130

Prominex Inc Pipeline Products & Ongoing Clinical Trials Overview 131

Validex System – Product Status 131

Validex System – Product Description 131

Qvella Corp Pipeline Products & Ongoing Clinical Trials Overview 132

FAST (Field Activated Sample Treatment) ID System – Product Status 132

FAST (Field Activated Sample Treatment) ID System – Product Description 132

Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 133

Radisens Instrument – Product Status 133

Radisens Instrument – Product Description 133

Rapid Diagnostic Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

MiniLab – Product Status 134

MiniLab – Product Description 134

RMIT University Pipeline Products & Ongoing Clinical Trials Overview 135

Point-Of-Care Device – Type 1 Diabetes – Product Status 135

Point-Of-Care Device – Type 1 Diabetes – Product Description 135

Samvardhana Motherson Health Solution Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

Motherson IVD Analyzer – Product Status 136

Motherson IVD Analyzer – Product Description 136

Scryb Inc Pipeline Products & Ongoing Clinical Trials Overview 137

HemoPalm-CX – Product Status 137

HemoPalm-CX – Product Description 137

SeLux Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 138

POC Device – Fertility – Product Status 138

POC Device – Fertility – Product Description 138

SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 139

SenGenix Strips And Reader System – Product Status 139

SenGenix Strips And Reader System – Product Description 139

SepTec Pipeline Products & Ongoing Clinical Trials Overview 140

SepTec – Product Status 140

SepTec – Product Description 140

Smiths Detection Inc Pipeline Products & Ongoing Clinical Trials Overview 141

Bio-Seeq – Clinical – Product Status 141

Bio-Seeq – Clinical – Product Description 141

StemTek Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 142

POC System – Cancer – Product Status 142

POC System – Cancer – Product Description 142

Sugentech Inc Pipeline Products & Ongoing Clinical Trials Overview 143

INCLIX H Analyzer – Product Status 143

INCLIX H Analyzer – Product Description 143

Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 144

FlashDirect-HC – Product Status 144

FlashDirect-HC – Product Description 144

FlashDirect-LC – Product Status 145

FlashDirect-LC – Product Description 145

ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 146

Biosensor System – Sepsis – Product Status 146

Biosensor System – Sepsis – Product Description 146

Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 147

Meritas Point of Care Analyzer – Product Status 147

Meritas Point of Care Analyzer – Product Description 148

Tri-stat 2 Analyzer – Product Status 148

Tri-stat 2 Analyzer – Product Description 148

University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 149

Diagnostic Tool – Brain Injury – Product Status 149

Diagnostic Tool – Brain Injury – Product Description 149

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 150

Microfluidic Blotting Device – Product Status 150

Microfluidic Blotting Device – Product Description 150

Point-Of-Care Microfluidic Device – Acute Promyelocytic Leukemia – Product Status 151

Point-Of-Care Microfluidic Device – Acute Promyelocytic Leukemia – Product Description 151

University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 152

Handheld Diagnostic Device – Product Status 152

Handheld Diagnostic Device – Product Description 152

University of Glasgow – Ongoing Clinical Trials Overview 153

Handheld Diagnostic Device – Optimising a Digital Diagnostic Pathway for Heart Failure in the Community 154

University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview 155

Electronic Point Of Care System – Product Status 155

Electronic Point Of Care System – Product Description 155

SPOT – Product Status 156

SPOT – Product Description 156

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 157

CardioSense – Product Status 157

CardioSense – Product Description 157

Ural Federal University Pipeline Products & Ongoing Clinical Trials Overview 158

Electrochemical Analyzer – Product Status 158

Electrochemical Analyzer – Product Description 158

ViroGates AS Pipeline Products & Ongoing Clinical Trials Overview 159

HemoSpec – Product Status 159

HemoSpec – Product Description 159

Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 160

Electrochemiluminescent Based RNA Detection Platform – Product Status 160

Electrochemiluminescent Based RNA Detection Platform – Product Description 160

Glossary 184

Figures

Point of Care (POC) Analyzers – Pipeline Products by Stage of Development 16_x000D_

Point of Care (POC) Analyzers – Pipeline Products by Segment 17_x000D_

Point of Care (POC) Analyzers – Pipeline Products by Territory 18_x000D_

Point of Care (POC) Analyzers – Pipeline Products by Regulatory Path 19_x000D_

Point of Care (POC) Analyzers – Pipeline Products by Estimated Approval Date 20_x000D_

Point of Care (POC) Analyzers – Ongoing Clinical Trials 21_x000D_

Frequently asked questions

Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.